Xponance’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,163
| Closed | -$211K | – | 1262 |
|
|
2023
Q2 | $211K | Buy |
+5,163
| New | +$211K | ﹤0.01% | 1136 |
|
|
2022
Q4 | – | Sell |
-4,250
| Closed | -$238K | – | 1240 |
|
|
2022
Q3 | $238K | Buy |
4,250
+210
| +5% | +$11.8K | ﹤0.01% | 1057 |
|
|
2022
Q2 | $209K | Buy |
4,040
+732
| +22% | +$37.9K | ﹤0.01% | 1085 |
|
|
2022
Q1 | $240K | Buy |
3,308
+14
| +0.4% | +$1.02K | ﹤0.01% | 1068 |
|
|
2021
Q4 | $389K | Buy |
3,294
+47
| +1% | +$5.55K | 0.01% | 990 |
|
|
2021
Q3 | $436K | Sell |
3,247
-251
| -7% | -$33.7K | 0.01% | 942 |
|
|
2021
Q2 | $566K | Buy |
+3,498
| New | +$566K | 0.01% | 868 |
|